Beyond the "Narrow Door": A Real-World Portrait of Early-Stage Frontier Biotech Entrepreneurship in China | FreeS Fund 2020 Biotech Summit Registration Now Open
Will Today’s US Biotech Become China’s Tomorrow?
Articles
FreeS Fund Wins Multiple Awards from Zero2IPO, ChinaVenture, and Cyzone; See You Tomorrow at 9 AM in the Live Room | Frees Fund Vol. 4
Looking forward to having you join us!
How to Manage and Motivate Organizations Well? Huawei's Former Head of Financing: Respect Human Nature, Distribute Money Right, and Live in Fear | Ronghui
Focus your force through a single point, and the returns will flow through that same point.
5Y Capital Day 1: The You Others Thought Was Crazy, Starting to Be Believed
Setting out anew — the same team, the same founding vision.
Domestic skincare brand PMPM raises tens of millions of yuan in pre-A and pre-A+ rounds, with Source Code Capital as sole angel investor
Launched less than six months ago, it has accumulated nearly RMB 50 million in GMV, growing 100x in just over six months.
Hangzhou Nationalchip Technology Completes Hundreds of Millions of Yuan in Series C Funding
Focused on chip design and system solutions for digital television and AIoT (AI + IoT).
Source Code Capital Closes RMB 3.8 Billion for Fourth RMB Fund
Late-stage investment, qualitative transformation, organizational capability
Li Feng: One Chart to Decode Biotech Innovation Opportunities | Your Complete Guide to the FreeS Fund 2020 Biomedical Summit
Three Livestreams and One Offline Symposium, Decoding the Era of Biomedical Innovation
Source Code Capital Wins Multiple Awards in Zero2IPO's 2020 China Equity Investment Annual Rankings
Create Lasting, Real Value
Farewell to Tradition, Decoding Complexity: How Can the Insurance Industry Transform and Upgrade? | FreeS Fund Fintech Venture Capital Summit Transcript
How Can Insurtech Serve the 800 Million People Without Coverage?